Golden Pine Ventures Logo

Contact:
Christopher S. Meldrum, Managing Director
E-mail:

For Immediate Release

Pique Therapeutics selected to present at CED's Venture 2006
– Company will be early-stage presenter at May conference–

DURHAM, NC. -- Feb. 23, 2006 -- The Council for Entrepreneurial Development (CED) has selected Pique Therapeutics to present at Venture 2006. Scheduled for May 2-3, 2006, at Pinehurst Resort in Pinehurst, NC, CED’s Venture 2006 conference will continue a 23-year tradition of showcasing North Carolina’s innovation economy and leading investment opportunities.

Venture 2006 is one of the Southeast's premier venture financing conferences. Presented by CED, Venture 2006 will showcase North Carolina's leading early and later-stage companies to hundreds of venture capitalists and financiers from throughout the United States. Since 1999, Venture presenters have raised over $1.8 billion in venture capital.

For more information on the Venture 2006 selected companies, visit http://www.cednc.org/conferences/venture/2006/presenters/.

In addition to company presentations, Venture 2006 (www.cednc.org/venture) will include leading industry speakers, extensive networking opportunities and exclusive investor-only events. Last year's conference, Venture 2005, drew a crowd of close to 700 investors, service professionals, entrepreneurs and others involved in the entrepreneurial funding process from throughout the United States.

About Pique Therapeutics
Pique Therapeutics is a biotechnology company seeking to become the leader in therapeutic vaccines, focused initially on the treatment of cancer. The company's lead product is a first-in-class therapeutic vaccine for non-small cell lung cancer and has completed Phase 1 clinical trials. Pique’s novel technology affords it the opportunity to create therapeutic vaccines for many additional areas of oncology, such as pancreatic cancer, colon cancer, and head and neck cancer. www.piquetherapeutics.com.

About CED
The Council for Entrepreneurial Development (CED) is a private, non-profit organization formed in 1984 to identify, enable and promote high growth, high impact entrepreneurial companies and to accelerate the entrepreneurial culture of the Research Triangle and North Carolina. CED is the largest and oldest entrepreneurial support organization in the nation with more than 4,000 members representing over 1,100 entrepreneurial companies, financiers and professional firms. In July 2005, Wilmington’s Coastal Entrepreneurial Council merged with CED to create CED-Coastal, a divisional office focused on entrepreneurial development in Wilmington and throughout North Carolina’s entire coastal region. CED provides education, mentoring and capital formation resources to new and existing high-growth entrepreneurs through annual conferences, seminars, workshops and programs on entrepreneurial management and finance. www.cednc.org.

About Golden Pine Ventures, LLC
Golden Pine Ventures works with scientists and entrepreneurs to form new portfolio companies, provides the necessary business and management expertise, funds all initial working capital needs, and raises high-valuation follow-on rounds of financing.  Current Golden Pine Ventures’ portfolio companies include: Pique Therapeutics, Kylin Therapeutics, and Exigent Pharmaceuticals.  For more information, please visit www.goldenpineventures.com